Table 2. Clinicopathological characteristics of cfDNA patients.
| Healthy Volunteers N (%) | Chronic Pancreatitis N (%) | PDAC N (%) | |
|---|---|---|---|
| Total number of patients | 12 | 14 | 26 |
| cfDNA (ng/ml) | |||
| Median | 175 | 300 | 585 |
| Range | 100-340 | 130-1000 | 120-4180 |
| Age (years) | |||
| Median | 55 | 56 | 69 |
| Range | 40-83 | 19-71 | 40-84 |
| Sex | |||
| Male | 2 (17) | 10 (72) | 16 (62) |
| Female | 10 (83) | 3 (21) | 10 (38) |
| Unknown | 0 (0) | 1 (7) | 0 (0) |
| Ethnicity | |||
| Caucasian | na | na | 25 (96) |
| Other | 1 (4) | ||
| TNM Staging | |||
| I/II | - | - | 7 (27) |
| III | - | - | 2 (8) |
| IV | - | - | 16 (61) |
| Unknown | - | - | 1 (4) |
| Site of Tumour | |||
| Head | - | - | 19 (73) |
| Body, Tail, Neck | - | - | 6 (23) |
| Unknown | - | - | 1 (4) |
| Ca19.9 levels (U/ml) | |||
| ≤ 37 | - | - | 3 (11) |
| > 37 | - | - | 15 (58) |
| Not Tested | - | - | 8 (31) |
| Survival (days) | |||
| Median | na | 1482 | 148 |
| Range | 101-1579 | 17-1460 | |
| Disease Specific Survival | |||
| Alive | na | 11 (79) | 1 (4) |
| Cancer death | 0 (0) | 25 (96) | |
| Non Cancer death | 3 (21) | 0 (0) |
na; data not available, -; not applicable to patient cohort.